Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

37 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Pilot clinical trial on the efficacy of prophylactic use of vitamin K1-based cream (Vigorskin) to prevent cetuximab-induced skin rash in patients with metastatic colorectal cancer.
Pinta F, Ponzetti A, Spadi R, Fanchini L, Zanini M, Mecca C, Sonetto C, Ciuffreda L, Racca P. Pinta F, et al. Among authors: mecca c. Clin Colorectal Cancer. 2014 Mar;13(1):62-7. doi: 10.1016/j.clcc.2013.10.001. Epub 2013 Nov 13. Clin Colorectal Cancer. 2014. PMID: 24332355 Clinical Trial.
Circannual variation of efficacy outcomes in patients with newly diagnosed metastatic colorectal cancer and treated with first-line chemotherapy.
Tampellini M, Polverari RS, Ottone A, Alabiso I, Baratelli C, Bitossi R, Brizzi MP, Leone F, Forti L, Bertona E, Racca P, Mecca C, Alabiso O, Aglietta M, Berruti A, Scagliotti GV. Tampellini M, et al. Among authors: mecca c. Chronobiol Int. 2015;32(10):1359-66. doi: 10.3109/07420528.2015.1093495. Epub 2015 Nov 5. Chronobiol Int. 2015. PMID: 26540634 Free article.
Bone metastases in gastric cancer follow a RANKL-independent mechanism.
D'Amico L, Satolli MA, Mecca C, Castiglione A, Ceccarelli M, D'Amelio P, Garino M, De Giuli M, Sandrucci S, Ferracini R, Roato I. D'Amico L, et al. Among authors: mecca c. Oncol Rep. 2013 Apr;29(4):1453-8. doi: 10.3892/or.2013.2280. Epub 2013 Feb 6. Oncol Rep. 2013. PMID: 23404437 Free article.
ALK inhibitors increase ALK expression and sensitize neuroblastoma cells to ALK.CAR-T cells.
Bergaggio E, Tai WT, Aroldi A, Mecca C, Landoni E, Nüesch M, Mota I, Metovic J, Molinaro L, Ma L, Alvarado D, Ambrogio C, Voena C, Blasco RB, Li T, Klein D, Irvine DJ, Papotti M, Savoldo B, Dotti G, Chiarle R. Bergaggio E, et al. Among authors: mecca c. Cancer Cell. 2023 Dec 11;41(12):2100-2116.e10. doi: 10.1016/j.ccell.2023.11.004. Epub 2023 Nov 30. Cancer Cell. 2023. PMID: 38039964
Comparing T Cell Subsets in Broncho-Alveolar Lavage (BAL) and Peripheral Blood in Patients with Advanced Lung Cancer.
Mariniello A, Tabbò F, Indellicati D, Tesauro M, Rezmives NA, Reale ML, Listì A, Capelletto E, Carnio S, Bertaglia V, Mecca C, Consito L, De Filippis M, Bungaro M, Paratore C, Di Maio M, Passiglia F, Righi L, Sangiolo D, Novello S, Geuna M, Bironzo P. Mariniello A, et al. Among authors: mecca c. Cells. 2022 Oct 14;11(20):3226. doi: 10.3390/cells11203226. Cells. 2022. PMID: 36291098 Free PMC article.
Next-generation ALK inhibitors are highly active in ALK-positive large B-cell lymphoma.
Soumerai JD, Rosenthal A, Harkins S, Duffy J, Mecca C, Wang Y, Grewal RK, El-Jawahri AR, Liu H, Menard C, Dogan A, Yang L, Rimsza LM, Bantilan K, Martin H, Lei M, Mohr S, Kurilovich A, Kudryashova O, Postovalova E, Nardi V, Abramson JS, Chiarle R, Zelenetz AD, Louissaint A Jr. Soumerai JD, et al. Among authors: mecca c. Blood. 2022 Oct 20;140(16):1822-1826. doi: 10.1182/blood.2022015443. Blood. 2022. PMID: 35802834 Free PMC article. No abstract available.
37 results